Endocrine disruptive chemicals: Mechanisms of action and involvement in metabolic disorders

Journal of Molecular Endocrinology

Volumn 43, Issue 1, 2009, Pages 1-10

  Swedenborg, Elin ^a   Rüegg, Joëlle ^a   Mäkelä, Sari ^b   Pongratz, Ingemar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; AROMATIC HYDROCARBON RECEPTOR; CELL NUCLEUS RECEPTOR; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR; FAT; FLAME RETARDANT; GLUCOSE; PERFLUORO COMPOUND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYBROMINATED DIPHENYL ETHER; POLYCHLORINATED BIPHENYL; RETINOID X RECEPTOR;

ATHEROSCLEROSIS; DISORDERS OF CARBOHYDRATE METABOLISM; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ENVIRONMENTAL EXPOSURE; HEALTH HAZARD; HORMONE METABOLISM; HORMONE RECEPTOR INTERACTION; HUMAN; INTERACTIONS WITH DNA; METABOLIC DISORDER; METABOLIC SYNDROME X; MOLECULAR INTERACTION; NONHUMAN; OBESITY; POLLUTION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TOXICOLOGY; TRANSCRIPTION REGULATION;

ANIMALS; ENDOCRINE DISRUPTORS; HUMANS; METABOLIC DISEASES; RECEPTORS, CELL SURFACE;

EID: 67650848116     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-08-0132     Document Type: Review

References (77)

1. Alonso-Magdalena P, Ropero AB, Carrera MP, Cederroth CR, Baquie M, Gauthier BR, Nef S, Stefani E & Nadal A 2008 Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS ONE 3 e2069.
2. Appel KE 2004 Organotin compounds: toxicokinetic aspects. Drug Metabolism Reviews 36 763-786.
3. Arcaro KF, O'Keefe PW, Yang Y, Clayton W & Gierthy JF 1999 Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells. Toxicology 133 115-127.
4. Arsenescu V, Arsenescu RI, King V, Swanson H & Cassis LA 2008 Polychlorinated biphenyl-77 induces adipocyte differentiation and proinflammatory adipokines and promotes obesity and atherosclerosis. Environmental Health Perspectives 116 761-768.
5. Asakawa A, Toyoshima M, Harada KH, Fujimiya M, Inoue K & Koizumi A 2008 The ubiquitous environmental pollutant perfluorooctanoicacid inhibits feeding behavior via peroxisome proliferator-activated receptor-alpha. International Journal of Molecular Medicine 21 439-445.
6. Baillie-Hamilton PF 2002 Chemical toxins: a hypothesis to explain the global obesity epidemic. Journal of Alternative and Complementary Medicine 8 185-192.
7. Baker ME, Medlock KL & Sheehan DM 1998 Flavonoids inhibit estrogen binding to rat alpha-fetoprotein. Proceedings of the Society for Experimental Biology and Medicine 217 317-321.
8. Boas M, Feldt-Rasmussen U, Skakkebaek NE & Main KM 2006 Environmental chemicals and thyroid function. European Journal of Endocrinology 154 599-611.
9. Bonefeld-Jorgensen EC, Long M, Hofmeister MV & Vinggaard AM 2007 Endocrine-disrupting potential of bisphenol A, bisphenol A dimethacrylate, 4-n-nonylphenol, and 4-n-octylphenol in vitro: new data and a brief review. Environmental Health Perspectives 115 69-76.
10. Brunnberg S, Pettersson K, Rydin E, Matthews J, Hanberg A & Pongratz I 2003 The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription. PNAS 100 6517-6522.
11. Butenhoff J, Costa G, Elcombe C, Farrar D, Hansen K, Iwai H, Jung R, Kennedy G Jr, Lieder P, Olsen G et al. 2002 Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicological Sciences 69 244-257.
12. Claessens F & Gewirth DT 2004 DNA recognition by nuclear receptors. Essays in Biochemistry 40 59-72.
13. Colborn T 2004 Neurodevelopment and endocrine disruption. Environmental Health Perspectives 112 944-949.
14. Darnerud PO 2003 Toxic effects of brominated flame retardants in man and in wildlife. Environment International 29 841-853.
15. Darnerud PO 2008 Brominated flame retardants as possible endocrine disrupters. International Journal of Andrology 31 152-160.
16. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodes-Cabau J, Bertrand OF & Poirier P 2008 Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arteriosclerosis, Thrombosis, and Vascular Biology 28 1039-1049.
17. Elobeid MA & Allison DB 2008 Putative environmental-endocrine disruptors and obesity: a review. Current Opinion in Endocrinology, Diabetes and Obesity 15 403-408.
18. Fierens S, Mairesse H, Heilier JF, De Burbure C, Focant JF, Eppe G, De Pauw E & Bernard A 2003 Dioxin/polychlorinated biphenyl body burden, diabetes and endometriosis: findings in a population-based study in Belgium. Biomarkers 8 529-534.
19. Foryst-Ludwig A, Clemenz M, Hohmann S, Hartge M, Sprang C, Frost N, Krikov M, Bhanot S, Barros R, Morani A et al. 2008 Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genetics 4 e1000108.
20. Gronemeyer H, Gustafsson JA & Laudet V 2004 Principles for modulation of the nuclear receptor superfamily. Nature Review Drug Discovery 3 950-964.
21. Grun F & Blumberg B 2006 Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147 S50-S55.
22. Grun F, Watanabe H, Zamanian Z, Maeda L, Arima K, Cubacha R, Gardiner DM, Kanno J, Iguchi T & Blumberg B 2006 Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Molecular Endocrinology 20 2141-2155.
23. Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, O'Connell PJ, Gonzalez FJ et al. 2005 Loss of ARNT/ HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122 337-349.
24. Hankinson O 2005 Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Archives of Biochemistry and Biophysics 433 379-386.
25. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB & Cooke PS 2000 Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. PNAS 97 12729-12734.
26. Hockings JK, Thorne PA, Kemp MQ, Morgan SS, Selmin O & Romagnolo DF 2006 The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen. Cancer Research 66 2224-2232.
27. Hoppe AA & Carey GB 2007 Polybrominated diphenyl ethers as endocrine disruptors of adipocyte metabolism. Obesity 15 2942-2950.
28. Howdeshell KL, Peterman PH, Judy BM, Taylor JA, Orazio CE, Ruhlen RL & Welshons WV 2003 Bisphenol A is released from used polycarbonate animal cages into water at room temperature. Environmental Health Perspectives 111 1180-1187.
29. Hugo ER 2008 Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environmental Health Perspectives 116 1642-1647.
30. Janosek J, Hilscherova K, Blaha L & Holoubek I 2006 Environmental xenobiotics and nuclear receptors-interactions, effects and in vitro assessment. Toxicology in Vitro 20 18-37.
31. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB & Melzer D 2008 Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300 1303-1310.
32. Le HH, Carlson EM, Chua JP & Belcher SM 2008 Bisphenol A is released from polycarbonate drinking bottles and mimics the neurotoxic actions of estrogen in developing cerebellar neurons. Toxicology Letters 176 149-156.
33. Lee JW, Lee YC, Na SY, Jung DJ & Lee SK 2001 Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors. Cellular and Molecular Life Sciences 58 289-297.
34. Lee DH, Lee IK, Song K, Steffes M, Toscano W, Baker BA & Jacobs DR Jr 2006 A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002. Diabetes Care 29 1638-1644.
35. Lee DH, Lee IK, Jin SH, Steffes M & Jacobs DR Jr 2007a Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 30 622-628.
36. Lee DH, Lee IK, Porta M, Steffes M & Jacobs DR Jr 2007b Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia 50 1841-1851.
37. Lee DH, Lee IK, Steffes M & Jacobs DR Jr 2007c Extended analyses of the association between serum concentrations of persistent organic pollutants and diabetes. Diabetes Care 30 1596-1598.
38. Gronemeyer H, Gustafsson JA & Laudet V 2004 Principles for modulation of the nuclear receptor superfamily. Nature Review Drug Discovery 3 950-964.
39. Grun F & Blumberg B 2006 Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147 S50-S55.
40. Grun F, Watanabe H, Zamanian Z, Maeda L, Arima K, Cubacha R, Gardiner DM, Kanno J, Iguchi T & Blumberg B 2006 Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Molecular Endocrinology 20 2141-2155.
41. Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, O'Connell PJ, Gonzalez FJ et al. 2005 Loss of ARNT/ HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122 337-349.
42. Hankinson O 2005 Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor. Archives of Biochemistry and Biophysics 433 379-386.
43. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB & Cooke PS 2000 Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. PNAS 97 12729-12734.
44. Hockings JK, Thorne PA, Kemp MQ, Morgan SS, Selmin O & Romagnolo DF 2006 The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen. Cancer Research 66 2224-2232.
45. Hoppe AA & Carey GB 2007 Polybrominated diphenyl ethers as endocrine disruptors of adipocyte metabolism. Obesity 15 2942-2950.
46. Howdeshell KL, Peterman PH, Judy BM, Taylor JA, Orazio CE, Ruhlen RL & Welshons WV 2003 Bisphenol A is released from used polycarbonate animal cages into water at room temperature. Environmental Health Perspectives 111 1180-1187.
47. Hugo ER 2008 Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environmental Health Perspectives 116 1642-1647.
48. Janosek J, Hilscherova K, Blaha L & Holoubek I 2006 Environmental xenobiotics and nuclear receptors-interactions, effects and in vitro assessment. Toxicology in Vitro 20 18-37.
49. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB & Melzer D 2008 Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300 1303-1310.
50. Le HH, Carlson EM, Chua JP & Belcher SM 2008 Bisphenol A is released from polycarbonate drinking bottles and mimics the neurotoxic actions of estrogen in developing cerebellar neurons. Toxicology Letters 176 149-156.
51. Lee JW, Lee YC, Na SY, Jung DJ & Lee SK 2001 Transcriptional coregulators of the nuclear receptor superfamily: coactivators and corepressors. Cellular and Molecular Life Sciences 58 289-297.
52. Lee DH, Lee IK, Song K, Steffes M, Toscano W, Baker BA & Jacobs DR Jr 2006 A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002. Diabetes Care 29 1638-1644.
53. Lee DH, Lee IK, Jin SH, Steffes M & Jacobs DR Jr 2007a Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 30 622-628.
54. Lee DH, Lee IK, Porta M, Steffes M & Jacobs DR Jr 2007b Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetologia 50 1841-1851.
55. Lee DH, Lee IK, Steffes M & Jacobs DR Jr 2007c Extended analyses of the association between serum concentrations of persistent organic pollutants and diabetes. Diabetes Care 30 1596-1598.
56. Reen RK, Cadwallader A & Perdew GH 2002 The subdomains of the transactivation domain of the aryl hydrocarbon receptor (AhR) inhibit AhR and estrogen receptor transcriptional activity. Archives of Biochemistry and Biophysics 408 93-102.
57. Rüegg J, Swedenborg E, Wahlstrom D, Escande A, Balaguer P, Pettersson K & Pongratz I 2007 The transcription factor ARNT functions as an estrogen receptor beta selective co-activator, and its recruitment to alternative pathways mediates anti-estrogenic effects of TCDD. Molecular Endocrinology 22 304-316.
58. Rüegg J, Penttinen-Damdimopoulou P, Mäkelä S, Pongratz I & Gustafsson J 2008 Receptors mediating toxicity and their involvement in endocrine disruption. In Molecular, Clinical and Environmental Toxicology, pp 298-324. Ed A Luch. Basel: Birkhäuser Verlag AG.
59. Safe S & Wormke M 2003 Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. Chemical Research in Toxicology 16 807-816.
60. Sato S, Shirakawa H, Tomita S, Ohsaki Y, Haketa K, Tooi O, Santo N, Tohkin M, Furukawa Y, Gonzalez FJ et al. 2008 Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver. Toxicology and Applied Pharmacology 229 10-19.
61. Singleton DW & Khan SA 2003 Xenoestrogen exposure and mechanisms of endocrine disruption. Frontiers in Bioscience 8 s110-s118.
62. Sugden MC & Holness MJ 2008 Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance. Biochemical Society Transactions 36 891-900.
63. Swanson HI 2002 DNA binding and protein interactions of the AHR/ARNT heterodimer that facilitate gene activation. Chemico-Biological Interactions 141 63-76.
64. Swedenborg E, Rüegg J, Hillenweck A, Rehnmark S, Faulds MH, Zalko D, Pongratz I & Pettersson K 2008 3-Methylcholanthrene displays dual effects on estrogen receptor (ER) alpha and ER beta signaling in a cell-type specific fashion. Molecular Pharmacology 73 575-586.
65. Tabb MM & Blumberg B 2006 New modes of action for endocrine-disrupting chemicals. Molecular Endocrinology 20 475-482.
66. Takeda K, Toda K, Saibara T, NakagawaM, Saika K, Onishi T, Sugiura T & Shizuta Y 2003 Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. Journal of Endocrinology 176 237-246.
67. Thackaberry EA, Bedrick EJ, Goens MB, Danielson L, Lund AK, Gabaldon D, Smith SM & Walker MK 2003 Insulin regulation in AhR-null mice: embryonic cardiac enlargement, neonatal macrosomia, and altered insulin regulation and response in pregnant and aging AhR-null females. Toxicological Sciences 76 407-417.
68. Thomas P, Pang Y, Filardo EJ & Dong J 2005 Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146 624-632.
69. Thomas P & Dong J 2006 Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. Journal of Steroid Biochemistry and Molecular Biology 102 175-179.
70. Tsuchiya Y, Nakajima M & Yokoi T 2005 Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Letters 227 115-124.
71. Vandenberg LN, Hauser R, Marcus M, Olea N & Welshons WV 2007 Human exposure to bisphenol A (BPA). Reproductive Toxicology 24 139-177.
72. Vidaeff AC & Sever LE 2005 In utero exposure to environmental estrogens and male reproductive health: a systematic review of biological and epidemiological evidence. Reproductive Toxicology 20 5-20.
73. Wang X, Porter W, Krishnan V, Narasimhan TR & Safe S 1993 Mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated decrease of the nuclear estrogen receptor in MCF-7 human breast cancer cells. Molecular Cellullar Endocrinology 96 159-166.
74. Watson G 2005. The Generations X report. WWF DetoX Campaign
75. Welshons WV, Nagel SC & vom Saal FS 2006 Large effects from small exposures, III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147 S56-S69.
76. Wu Y & Koenig RJ 2000 Gene regulation by thyroid hormone. Trends in Endocrinology and Metabolism 11 207-211.
77. You L, Sar M, Bartolucci E, Ploch S & Whitt M 2001 Induction of hepatic aromatase by p, p'-DDE in adult male rats. Molecular Cellullar Endocrinology 178 207-214.